Nina Hobi, AlveoliX AG - Qepler Summits And Conferences

Nina Hobi

CEO & Scientific Director
AlveoliX AG
Bern, Switzerland
AlveoliX AG

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2021

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 05 Aug 2021
  • Virtual,
  • Pharma
Day 1: Thursday, 05 August 2021
CASE STUDY: Lung on chip applications in respiratory health
View Details